About OmerosPipelineInvestorsNews

Receive E-mail AlertsE-mail Alerts


Download Documentation Corporate Presentation
Get help downloading or viewing the above file types

OMIDRIA Manuscripts

Date Title Citation Author
2/18 Effect of Phenylephrine/Ketorolac on Iris Fixation Ring Use and Surgical Times in Patients at Risk of Intraoperative MiosisClin Ophthalmol. 2018;12:301-305Visco
12/17Visual outcomes, efficacy, and surgical complications associated with intracameral phenylephrine 1.0%/ketorolac 0.3% administered during cataract surgeryClin Ophthalmol. 2018;12:21-28Rosenberg
8/17Effect of Early Phenylephrine and Ketorolac Injection 1%/0.3% (Omidria ®) Usage on Pupil Diameter in Traditional and Femto-Assisted Cataract Surgery Abstract with Poster presentation at: 15th International Congress on Vision Science and Eye Gayton
10/17Intracameral ketorolac concentration at the beginning and end of cataract surgery following preoperative topical ketorolac administrationClin Ophthalmol. 2017:11 1897–1901Katsev
Alternative Drug Delivery for Patients Undergoing Cataract Surgery as Demonstrated in a Canine ModelJOPT. 2018; 34:154-160 Waterbury
6/17Intracameral ketorolac and phenylephrine effect on intraoperative pupil diameter and postoperative pain in cataract surgeryJCRS 2017; 43: 597-605Donnenfeld
6/17Comparison of the frequency of use of a pupil expansion device with and without an intracameral phenylephrine and ketorolac injection 1%/0.3% at the time of routine cataract surgeryClin Ophthalmol. 2017; 11: 1039-1043Bucci
5/17Importance of pupil dilation for cataract surgeryJCRS Editorial; Volume 43 Issue 5 May 2017Mammalis
12/16Letter to the Editor: An Alternative to Topical Dosing to Deliver Drugs to Target TissuesJOPT. 2016; 10: 1-2Waterbury
9/16Patient considerations in cataract surgery – the role of combined therapy using phenylephrine and ketorolacPatient Preference and Adherence 2016; 10: 1795-1801Gonzalez-Salinas
2/16Becoming a BelieverFebruary 2016 | Cataract & Refractive Surgery TodayWalter
10/15Intracameral phenylephrine and ketorolac during cataract surgery to maintain intraoperative mydriasis and reduce postoperative ocular pain: Integrated results from 2 pivotal phase 3 studiesJ Cataract Refract Surg. 2015; 41: 2060- 2068Hovanesian
7/15The clinical utility of new combination phenylephrine/ketorolac injection in cataract surgeryClin Ophthalmol. 2015; 9: 1249-1254Lawuyi
4/15Point/Counterpoint: A Disruptive Innovation or a Costly Disruption? April 2015 | Cataract & Refractive Surgery Today Donnenfeld / Walter
3/15OMS302 (phenylephrine and ketorolac injection) 1%/0.3% to maintain intraoperative pupil size and to prevent postoperative ocular pain in cataract surgery with intraocular lens replacementExpert Rev. Ophthalmol. 2015; 10(2): 91–103Osher
9/14Intracameral phenylephrine and ketorolac injection (OMS302) for maintenance of intraoperative pupil diameter and reduction of postoperative pain in intraocular lens replacement with phacoemulsificationClin Ophthalmol. 2014; 8: 1735-1744Lindstrom
7/14Management of mydriasis and pain in cataract and intraocular lens surgery: review of current medications and future directionsClin Ophthalmol. 2014; 8: 1281-1289Grob

OMS721 Posters

Date Meeting Title Author
11/17American Society of NephrologyMaintenance of Remission Following Completion of OMS721 Treatment in Patients with IgA Nephropathy (IGAN)Block
10/17European Society for Blood and Marrow Transplantation - Crash Course on Diagnosis and Treatment of Noninfectious Complications after HCTEffective Treatment of GvHD-Associated Transplant-Associated Microangiopathy with a Novel Inhibitor of the Lectin Pathway of ComplementCaprioli
06/1754th European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) CongressThe Effect of OMS721 on Proteinuria in Patients with IgA NephropathyBlock
04/17International Society of Nephrology (ISN) World Congress of NephrologyDose-Finding Clinical Trial of OMS721 for the Treatment of Atypical Hemolytic Uremic Syndrome (aHUS) – Stage 1 ResultsNowicki
03/1743rd Annual Meeting of the European Society for Blood and Marrow TransplantationResolution of acute kidney injury secondary to TA-TMA by the anti-MASP-2 monoclonal antibody OMS721 in a pediatric HSCT recipientZecca
02/172017 Tandem Meeting of the American Society of Blood and Marrow Transplantation and the Center for International Blood and Marrow Transplant ResearchEarly Results of Phase II Study Using OMS721 in Patients with Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (HCT-TMA)Khaled